{
    "2021-11-03": [
        [
            {
                "time": "",
                "original_text": "医药行业一周观察：三季报后板块表现分化 关注估值合理的优质标的",
                "features": {
                    "keywords": [
                        "医药行业",
                        "三季报",
                        "板块表现",
                        "估值合理",
                        "优质标的"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "A股收盘综述：“光伏茅”放量迫近跌停恫吓热门赛道，煤炭、地产、防疫板块逆势上扬",
                "features": {
                    "keywords": [
                        "A股",
                        "光伏茅",
                        "跌停",
                        "热门赛道",
                        "煤炭",
                        "地产",
                        "防疫板块",
                        "逆势上扬"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "光伏",
                        "煤炭",
                        "地产",
                        "防疫"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "港股异动 | 复星医药(02196)拉升7% 新冠疫苗增量前景被看好",
                "features": {
                    "keywords": [
                        "港股",
                        "复星医药",
                        "新冠疫苗",
                        "增量前景",
                        "被看好"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【异动股】复星医药(02196.HK)涨4.76%",
                "features": {
                    "keywords": [
                        "异动股",
                        "复星医药",
                        "涨4.76%"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}